Frequency of BRAF V600E mutations in 969 central nervous system neoplasms
2016 · Diagnostic Pathology · 110 citations
https://doi.org/10.1186/s13000-016-0506-2
F
Felix Behling
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
190
Papers
1.4K
Citations
19
h-index
41
i10-index
Felix Behling is an academic researcher from Center for Neuro-Oncology. The author has contributed to research in topics: Meningioma and schwannoma management & Glioma Diagnosis and Treatment & Immune cells in cancer. The author has an h-index of 19, co-authored 162 publications.
ORCID: 0000-0002-1083-1276Papers by this author
worksThe prognostic role of IDH mutations in homogeneously treated patients with anaplastic astrocytomas and glioblastomas
2019 · Acta Neuropathologica Communications · 72 citations
https://doi.org/10.1186/s40478-019-0817-0
The role of Simpson grading in meningiomas after integration of the updated WHO classification and adjuvant radiotherapy
2020 · Neurosurgical Review · 50 citations
https://doi.org/10.1007/s10143-020-01428-7
COX2 expression is associated with proliferation and tumor extension in vestibular schwannoma but is not influenced by acetylsalicylic acid intake
2019 · Acta Neuropathologica Communications · 20 citations
https://doi.org/10.1186/s40478-019-0760-0
Differences in the expression of SSTR1–5 in meningiomas and its therapeutic potential
2021 · Neurosurgical Review · 20 citations
https://doi.org/10.1007/s10143-021-01552-y
Frequent FGFR1 hotspot alterations in driver-unknown low-grade glioma and mixed neuronal-glial tumors
2022 · Journal of Cancer Research and Clinical Oncology · 19 citations
https://doi.org/10.1007/s00432-021-03906-x
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat